Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, +12

The Lancet

VaccinationVaccine SafetyNationwide Vaccination CampaignVaccine DevelopmentVaccine Surveillance +7

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof, Jeff Slezak, Heidi Fischer, +12

The Lancet

VaccinationVaccine SafetyRetrospective Cohort StudyPreventive MedicineVaccine Efficacy +4

<i>Salmonella</i>Paratyphi A Rates, Asia

R. Leon Ochiai, Xuanyi Wang, Lorenz von Seidlein, +11

Emerging infectious diseases

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow, +71

The Lancet Regional Health - Europe

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

John M. McLaughlin, Qin Jiang, Raúl Istúriz, +9

Clinical Infectious Diseases

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

Sara Y. Tartof, Jeff Slezak, Laura Puzniak, +6

The Lancet Respiratory Medicine

VaccinationVaccine SafetyVaccinologyBnt162b2 VaccineVaccine Development +8

Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study

Eric J. Haas, John M. McLaughlin, Farid Khan, +13

The Lancet Infectious Diseases

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Timothy L. Wiemken, Farid Khan, Laura Puzniak, +6

Scientific Reports

Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system

Joseph A. Lewnard, John M. McLaughlin, Vennis Hong, +8

The Lancet Infectious Diseases

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study

Sara Y. Tartof, Jeff Slezak, Laura Puzniak, +12

The Lancet Regional Health - Americas